New approach will help identify drugs that can 'glue' proteins together

Potential drug target for difficult-to-treat breast cancer: RNA-binding proteins

RNA-Binding Proteins: Molecular Targeted Therapy for Difficult-to-Treat Breast Cancer

BRIM Biotechnology’s lead candidate BRM421 for Dry Eye Syndrome shows promising results in Phase II clinical trials | Proteins and Peptides